/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Dr. Manan Pareek is an MD, PhD, FAHA, FESC, currently working as a resident in internal medicine. He has co-supervised 5 masters theses and co-mentored 5 PhD-students. He has almost 20 years of teaching experience. Dr. Pareek has been a volunteer member of the Danish Society of Cardiology since 2014 where he has authored or co-authored >20 guidelines and been on the endorsement committees for two ESC guidelines (dual antiplatelet therapy and hypertension). He is currently the chair of the Danish Working Group for Acute Coronary Syndromes and a nucleus member in the Working Group for Thrombosis. He has worked with hypertension, biomarkers, antiplatelet drugs, prediction of diabetes, cardiovascular disease, and mortality, and is the principal investigator of ASPRIN-C3 (NCT05932472). Finally, Dr. Pareek serves as a peer reviewer for >40 journals and has reviewed abstracts for the American Heart Association and ESC since 2018. He has authored or co-authored >135 peer-reviewed articles.
Serial changes in high-sensitivity troponin I levels indicate poorer prognosis in patients with suspected acute coronary syndrome who fail to reach a level greater than the 99th percentile
Event: ESC Congress 2020
Topic: Epidemiology, Prognosis, Outcome
Session: Acute Coronary Syndromes ePosters
